{"data":[{"accessionNo":"0002012383-26-003757","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001501796","issuerName":"AURA BIOSCIENCES INC","ticker":"AURA","cusip":"05153U107","securityClass":"Common Stock","eventDate":"2026-09-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":5219492,"percentOfClass":5.03,"filedAt":"2026-10-27","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001470831-26-000917","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":"05153U107","securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2026-09-25","reportingPerson":"Forbion Growth III Management B.V.","reportingCik":null,"personType":"OO","sharesOwned":5248841,"percentOfClass":5.1,"filedAt":"2026-10-01","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001470831-26-000917","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":"05153U107","securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2026-09-25","reportingPerson":"Forbion Growth Opportunities Fund III Cooperatief U.A.","reportingCik":null,"personType":"OO","sharesOwned":5248841,"percentOfClass":5.1,"filedAt":"2026-10-01","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001470831-26-000917","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":"05153U107","securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2026-09-25","reportingPerson":"ForGrowth III PA B.V.","reportingCik":null,"personType":"OO","sharesOwned":5248841,"percentOfClass":5.1,"filedAt":"2026-10-01","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001231919-26-000913","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":"05153U107","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-06-30","reportingPerson":"FHMLSP, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":5807260,"percentOfClass":5.6,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001231919-26-000913","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":"05153U107","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-06-30","reportingPerson":"Frazier Life Sciences Public Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":5807260,"percentOfClass":5.6,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001231919-26-000913","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":"05153U107","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-06-30","reportingPerson":"FHMLSP, L.P.","reportingCik":null,"personType":"PN","sharesOwned":5807260,"percentOfClass":5.6,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001019056-26-000129","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001501796","issuerName":"AURA BIOSCIENCES, INC.","ticker":"AURA","cusip":"05153U107","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"JOHN HELMERS","reportingCik":null,"personType":"IN","sharesOwned":5119582,"percentOfClass":4.9,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001019056-26-000129","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001501796","issuerName":"AURA BIOSCIENCES, INC.","ticker":"AURA","cusip":"05153U107","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"LONG FOCUS CAPITAL MANAGEMENT, LLC","reportingCik":null,"personType":"IA","sharesOwned":5119582,"percentOfClass":4.9,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001231919-26-000913","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":"05153U107","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-06-30","reportingPerson":"Frazier Life Sciences XII, L.P.","reportingCik":null,"personType":"PN","sharesOwned":805410,"percentOfClass":0.8,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001231919-26-000913","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":"05153U107","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-06-30","reportingPerson":"FHMLS XII, L.P.","reportingCik":null,"personType":"PN","sharesOwned":805410,"percentOfClass":0.8,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001231919-26-000913","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":"05153U107","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-06-30","reportingPerson":"FHMLS XII, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":805410,"percentOfClass":0.8,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001231919-26-000913","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":"05153U107","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-06-30","reportingPerson":"Frazier Life Sciences XI, L.P.","reportingCik":null,"personType":"PN","sharesOwned":358810,"percentOfClass":0.3,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001231919-26-000913","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":"05153U107","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-06-30","reportingPerson":"FHMLS XI, L.P.","reportingCik":null,"personType":"PN","sharesOwned":358810,"percentOfClass":0.3,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001231919-26-000913","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":"05153U107","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-06-30","reportingPerson":"FHMLS XI, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":358810,"percentOfClass":0.3,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001231919-26-000913","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":"05153U107","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-06-30","reportingPerson":"James N. Topper","reportingCik":null,"personType":"IN","sharesOwned":128520,"percentOfClass":0.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001231919-26-000913","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":"05153U107","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-06-30","reportingPerson":"Frazier Life Sciences X, L.P.","reportingCik":null,"personType":"PN","sharesOwned":128520,"percentOfClass":0.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001231919-26-000913","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":"05153U107","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-06-30","reportingPerson":"FHMLS X, L.P.","reportingCik":null,"personType":"PN","sharesOwned":128520,"percentOfClass":0.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001231919-26-000913","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":"05153U107","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-06-30","reportingPerson":"FHMLS X, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":128520,"percentOfClass":0.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001231919-26-000913","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":"05153U107","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-06-30","reportingPerson":"Patrick J. Heron","reportingCik":null,"personType":"IN","sharesOwned":128520,"percentOfClass":0.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0000919574-26-004960","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":"05153U107","securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2026-06-30","reportingPerson":"Adage Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":9104294,"percentOfClass":8.44,"filedAt":"2026-08-12","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0000919574-26-004960","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":"05153U107","securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2026-06-30","reportingPerson":"Robert Atchinson","reportingCik":null,"personType":"HC,IN","sharesOwned":9104294,"percentOfClass":8.44,"filedAt":"2026-08-12","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0000919574-26-004960","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":"05153U107","securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2026-06-30","reportingPerson":"Phillip Gross","reportingCik":null,"personType":"HC,IN","sharesOwned":9104294,"percentOfClass":8.44,"filedAt":"2026-08-12","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0002012383-26-002193","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001501796","issuerName":"AURA BIOSCIENCES INC","ticker":"AURA","cusip":"05153U107","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":4582436,"percentOfClass":4.4,"filedAt":"2026-07-27","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001193125-26-219992","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":"05153U107","securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2026-05-05","reportingPerson":"Chen Yu","reportingCik":null,"personType":"IN","sharesOwned":9533333,"percentOfClass":9.9,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001193125-26-219992","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":"05153U107","securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2026-05-05","reportingPerson":"TCG Crossover Fund II, L.P.","reportingCik":null,"personType":"PN","sharesOwned":4766667,"percentOfClass":5,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001193125-26-219992","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":"05153U107","securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2026-05-05","reportingPerson":"TCG Crossover GP III, LLC","reportingCik":null,"personType":"OO","sharesOwned":4766666,"percentOfClass":5,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001193125-26-219992","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":"05153U107","securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2026-05-05","reportingPerson":"TCG Crossover GP II, LLC","reportingCik":null,"personType":"OO","sharesOwned":4766667,"percentOfClass":5,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001193125-26-219992","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":"05153U107","securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2026-05-05","reportingPerson":"TCG Crossover Fund III, L.P.","reportingCik":null,"personType":"PN","sharesOwned":4766666,"percentOfClass":5,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0000950142-26-001345","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":"05153U107","securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2026-05-07","reportingPerson":"Matrix Capital Management Company LP","reportingCik":"0001410830","personType":"IA,PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-05-11","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0000950142-26-001345","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":"05153U107","securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2026-05-07","reportingPerson":"David E. Goel","reportingCik":null,"personType":"IN,HC","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-05-11","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001062993-26-001017","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2026-02-13","reportingPerson":"Rajesh Parekh, Ph.D.","reportingCik":null,"personType":"IN","sharesOwned":2071857,"percentOfClass":3.335,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001062993-26-001017","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2026-02-13","reportingPerson":"Advent-Harrington Impact Fund LP","reportingCik":null,"personType":"PN","sharesOwned":2023857,"percentOfClass":3.258,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001062993-26-001017","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2026-02-13","reportingPerson":"Advent Life Sciences LLP","reportingCik":null,"personType":"PN","sharesOwned":2023857,"percentOfClass":3.258,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001062993-26-001017","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2026-02-13","reportingPerson":"Advent Life Sciences Fund I LP","reportingCik":null,"personType":"PN","sharesOwned":2023857,"percentOfClass":3.258,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001062993-26-001017","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2026-02-13","reportingPerson":"Advent Life Sciences Fund III LP","reportingCik":null,"personType":"PN","sharesOwned":2023857,"percentOfClass":3.258,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001062993-26-001017","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2026-02-13","reportingPerson":"ALS III Carry and Co-Invest LP","reportingCik":null,"personType":"PN","sharesOwned":2023857,"percentOfClass":3.258,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001231919-26-000155","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":null,"securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2025-12-31","reportingPerson":"FHMLSP, L.P.","reportingCik":null,"personType":"PN","sharesOwned":4032060,"percentOfClass":6.3,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001231919-26-000155","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":null,"securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2025-12-31","reportingPerson":"Frazier Life Sciences Public Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":4032060,"percentOfClass":6.3,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001231919-26-000155","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":null,"securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2025-12-31","reportingPerson":"FHMLSP, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":4032060,"percentOfClass":6.3,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001231919-26-000155","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":null,"securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2025-12-31","reportingPerson":"FHMLS XII, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":597210,"percentOfClass":0.9,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001231919-26-000155","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":null,"securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2025-12-31","reportingPerson":"FHMLS XII, L.P.","reportingCik":null,"personType":"PN","sharesOwned":597210,"percentOfClass":0.9,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001231919-26-000155","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":null,"securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2025-12-31","reportingPerson":"Frazier Life Sciences XII, L.P.","reportingCik":null,"personType":"PN","sharesOwned":597210,"percentOfClass":0.9,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001231919-26-000155","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":null,"securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2025-12-31","reportingPerson":"FHMLS XI, L.P.","reportingCik":null,"personType":"PN","sharesOwned":342210,"percentOfClass":0.5,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001231919-26-000155","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":null,"securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2025-12-31","reportingPerson":"Frazier Life Sciences XI, L.P.","reportingCik":null,"personType":"PN","sharesOwned":342210,"percentOfClass":0.5,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001231919-26-000155","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":null,"securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2025-12-31","reportingPerson":"FHMLS XI, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":342210,"percentOfClass":0.5,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001231919-26-000155","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":null,"securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2025-12-31","reportingPerson":"FHMLS X, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":128520,"percentOfClass":0.2,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001231919-26-000155","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":null,"securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2025-12-31","reportingPerson":"FHMLS X, L.P.","reportingCik":null,"personType":"PN","sharesOwned":128520,"percentOfClass":0.2,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001231919-26-000155","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":null,"securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2025-12-31","reportingPerson":"Frazier Life Sciences X, L.P.","reportingCik":null,"personType":"PN","sharesOwned":128520,"percentOfClass":0.2,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001231919-26-000155","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":null,"securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2025-12-31","reportingPerson":"James N. Topper","reportingCik":null,"personType":"IN","sharesOwned":128520,"percentOfClass":0.2,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0001231919-26-000155","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001501796","issuerName":"Aura Biosciences, Inc.","ticker":"AURA","cusip":null,"securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2025-12-31","reportingPerson":"Patrick J. Heron","reportingCik":null,"personType":"IN","sharesOwned":128520,"percentOfClass":0.2,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/aura"},{"accessionNo":"0002012383-25-002503","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001501796","issuerName":"AURA BIOSCIENCES INC","ticker":"AURA","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":3336027,"percentOfClass":5.4,"filedAt":"2025-10-17","canonicalUrl":"https://xoomar.com/markets/stocks/aura"}],"updatedAt":"2026-11-03T20:29:46.410Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/aura","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}